What are the recommended dosing, administration guidelines, contraindications, and side effect profile of buspirone for treating generalized anxiety disorder?

Buspirone for Generalized Anxiety Disorder

Overview and FDA Indication

Buspirone is FDA-approved for the management of generalized anxiety disorder (GAD) and provides effective anxiolytic therapy without the sedation, dependence risk, or psychomotor impairment associated with benzodiazepines. 1

The medication is indicated for GAD characterized by persistent anxiety lasting at least 1 month, manifested by motor tension, autonomic hyperactivity, apprehensive expectation, and vigilance/scanning symptoms. 1

Dosing and Administration

Starting and Maintenance Dosing

• Initial dose: 7.5 mg twice daily (15 mg/day total) 1, 2
• Target therapeutic dose: 15-30 mg/day in divided doses 1, 3, 4
• Titrate upward in 5 mg increments every 2-3 days as needed 1
• Maximum dose: 60 mg/day 1

Dosing Frequency Options

• Both twice-daily (BID) and three-times-daily (TID) regimens are equally effective and well-tolerated 2
• For 30 mg/day: can administer as 15 mg BID or 10 mg TID with no appreciable difference in efficacy or safety 2

Important Timing Consideration

A critical caveat: buspirone has a 1-2 week "lag time" before anxiolytic effects become apparent 5. This requires:

• Patient education about delayed onset to maintain compliance 5
• Continued dosing despite lack of immediate symptom relief 3

Food Effects

• Administration with food slows absorption rate but increases bioavailability of unchanged drug 4
• Dosing should be consistent (always with food or always without food) 1

Contraindications

Absolute Contraindications

• Hypersensitivity to buspirone 1
• Concurrent use with MAOIs or within 14 days of MAOI discontinuation (due to serotonin syndrome risk and elevated blood pressure) 1
• Concurrent use with reversible MAOIs (linezolid, IV methylene blue) 1

Relative Contraindications/Cautions

• Severe hepatic or renal impairment - buspirone administration cannot be recommended due to increased plasma levels and prolonged half-life 1
• Patients requiring immediate anxiolytic effect (due to delayed onset) 5

Side Effect Profile

Common Adverse Effects

The most frequently reported side effects include:

• Dizziness 4, 6
• Nervousness 4
• Headache 4
• Nausea 1

Notably, sedation occurs much less frequently with buspirone compared to benzodiazepines 5, making it particularly advantageous when daytime alertness is important 5.

Serious but Rare Adverse Effects

• Serotonin syndrome when combined with other serotonergic agents 7
  • Symptoms: mental status changes, neuromuscular hyperactivity, autonomic hyperactivity 7
  • Can progress to fever, seizures, arrhythmias, unconsciousness 7
  • Requires immediate discontinuation and hospital-based supportive care 7

Drug Interactions

• Warfarin: One case report of prolonged prothrombin time; monitor INR closely 1
• CYP3A4 inhibitors/inducers: May affect buspirone metabolism 1
• Does NOT interact with alcohol (unlike benzodiazepines) 3, 5
• Does NOT cause psychomotor impairment or impair driving skills 4, 5

Laboratory Interference

Buspirone interferes with urinary metanephrine/catecholamine assays, causing false-positive results for pheochromocytoma 1

• Discontinue buspirone at least 48 hours before urine collection for catecholamines 1

Special Populations

Elderly Patients (≥65 years)

• No dose adjustment needed in elderly patients 6
• Safety and efficacy profiles similar to younger patients 1, 6
• 80% of elderly patients reported no side effects in large trial 6
• No unusual age-related adverse phenomena 6

Pediatric Patients (6-17 years)

• Buspirone did NOT demonstrate significant efficacy over placebo in pediatric GAD trials 1
• Doses of 15-60 mg/day studied showed no significant differences from placebo 1
• Plasma exposure equal to or higher than adults for identical doses 1
• Not recommended as first-line in this population based on lack of demonstrated efficacy 1

Pregnancy and Lactation

• Pregnancy Category B - no fetal damage in animal studies, but no adequate human studies 1
• Use only if clearly needed during pregnancy 1
• Avoid in nursing mothers - buspirone and metabolites excreted in rat milk 1

Clinical Advantages Over Benzodiazepines

Buspirone is likely the treatment of choice when prolonged therapy is indicated because: 3

• No physical dependence or withdrawal syndrome 3, 4
• No interaction with alcohol 3, 5
• No psychomotor impairment 3, 4
• Limited abuse potential 4, 5, 8
• Lack of lethality in overdose 8
• Maintains anxioselective properties without sedation, muscle relaxation, or anticonvulsant effects 4, 5

Critical Prescribing Pitfall: Prior Benzodiazepine Use

Patients recently discontinued from benzodiazepines (within 1 month) show reduced response to buspirone 9:

• Higher attrition rates with "lack of efficacy" as primary reason 9
• More frequent adverse events 9
• Smaller improvement compared to placebo 9

Clinical approach: When switching from benzodiazepines to buspirone, allow adequate washout period (≥1 month preferred) and provide extensive patient education about delayed onset and expected differences in effect 9.

Duration of Therapy

• Efficacy demonstrated for 3-4 weeks in controlled trials 1
• Long-term use (up to 1 year) studied in 264 patients without ill effect 1
• Periodically reassess usefulness for extended treatment beyond 3-4 weeks 1